Anlon Healthcare Intrinsic Value
AHCL Valuation Methods Summary
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹184.80 | ₹147.84 - ₹221.76 | +47.0% | EPS: ₹8.40, Sector P/E: 22x |
| Book Value Method | asset | ₹40.00 | ₹36.00 - ₹44.00 | -68.2% | Book Value/Share: ₹20.00, P/B: 2.0x |
| Revenue Multiple Method | revenue | ₹85.00 | ₹76.50 - ₹93.50 | -32.4% | Revenue/Share: ₹42.50, P/S: 2.0x |
| EBITDA Multiple Method | earnings | ₹125.00 | ₹112.50 - ₹137.50 | -0.6% | EBITDA: ₹50.00Cr, EV/EBITDA: 10x |
| PEG Ratio Method | growth | ₹134.40 | ₹120.96 - ₹147.84 | +6.9% | EPS Growth: 20.0%, Fair P/E: 16.0x |
| Growth Adjusted P/E | growth | ₹135.45 | ₹121.90 - ₹149.00 | +7.7% | Revenue Growth: 15.0%, Adj P/E: 16.1x |
| ROE Based Valuation | profitability | ₹140.00 | ₹126.00 - ₹154.00 | +11.3% | ROE: 43.8%, P/E Multiple: 16x |
| Graham Defensive Method | conservative | ₹40.00 | ₹36.00 - ₹44.00 | -68.2% | EPS: ₹8.40, BVPS: ₹20.00 |
Want to compare with current market value? Check AHCL share price latest .
Valuation Comparison Chart
AHCL Intrinsic Value Analysis
What is the intrinsic value of AHCL?
Based on our comprehensive analysis using 8 different valuation methods, the estimated intrinsic value of Anlon Healthcare (AHCL) is ₹134.40 (median value). With the current market price of ₹125.73, this represents a +6.9% variance from our estimated fair value.
The valuation range spans from ₹40.00 to ₹184.80, indicating ₹40.00 - ₹184.80.
Is AHCL undervalued or overvalued?
Based on our multi-method analysis, Anlon Healthcare (AHCL) appears to be trading near calculated value by approximately 6.9%.
Financial Health Analysis
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 3.88 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | 43.8% | Industry Standard: 15%+ | Above 15% | Measures shareholder return efficiency |
| Operating Margin | 29.0% | Industry Standard: 20%+ | Above 20% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.94x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
Related Pages for Anlon Healthcare
Additional stock information and data for AHCL
Cash Flow Quality Analysis
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-23 Cr | ₹-23 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-3 Cr | ₹-5 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-3 Cr | ₹-3 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-2 Cr | ₹-2 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-15 Cr | ₹-17 Cr | Negative Cash Flow | 3/10 |